Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Gene expression in brain during cuprizone-induced demyelination and remyelination.
Dynamics of B-Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and Mitoxantrone.
Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence.
Delayed visual evoked response in optic neuritis.
Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease.
Exposure levels of anti-LINGO-1 Li81 antibody in the central nervous system and dose-efficacy relationships in rat spinal cord remyelination models after systemic administration.
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
Neuroprotective dimethyl fumarate synergizes with immunomodulatory interferon beta to provide enhanced axon protection in autoimmune neuroinflammation.
Comparative efficacy of switching to natalizumab in active multiple sclerosis.
Multiple sclerosis, vitamin D, and HLA-DRB1*15.
Optical coherence tomography reflects brain atrophy in MS: A four year study.
Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.
Oral BG-12 (dimethyl fumarate) significantly reduced multiple sclerosis (MS) relapses and disability progression in DEFINE Phase 3 clinical trial
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β.
Interferon-β therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome.
MS disease activity in RESTORE: A randomized 24-week natalizumab treatment interruption study.
American Academy of Neurology 2012 Annual Meeting
XI European Meeting on Glia Cells in Health and Disease
TECFIDERA prescribing information
Demyelination and Remyelination: From Mechanism to Therapy
Episode 20 with Dr. Jeffrey Cohen discussing two MS-related clinical trials
Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis.
Status spongiosus of CNS and hepatic changes induced by cuprizone (biscyclohexanone oxalyldihydrazone).
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.
Cuprizone demyelination of the corpus callosum in mice correlates with altered social interaction and impaired bilateral sensorimotor coordination.

Pages